日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD-1 inhibitor treatment outcomes for cutaneous squamous cell carcinoma in patients over 85: a comparative analysis

PD-1抑制剂治疗85岁以上皮肤鳞状细胞癌患者的疗效:一项比较分析

Amir, Ido; Edri, Nofar; Averbuch, Itamar; Asher, Nethanel; Markel, Gal; Ritter, Amit; Yaniv, Dan; Zavdy, Ofir; Bachar, Gideon; Cooper, Lisa; Kurman, Noga; Yosefof, Eyal

Ethical concerns about embodied brain organoids shaped by foundational distinctions and perceptions of consciousness

具身脑类器官的伦理问题源于对意识的基本区分和认知。

Boyd, J Lomax; Jensen, Eric Allen; Jensen, Aaron Michael; Lipshitz, Nethanel

A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases

比较肢体灌注/输注、免疫检查点抑制剂和病灶内治疗作为黑色素瘤转移患者一线治疗的疗效

DePalo, Danielle K; Dugan, Michelle M; Naqvi, Syeda Mahrukh Hussnain; Ollila, David W; Hieken, Tina J; Block, Matthew S; van Houdt, Winan J; Wouters, Michel W J M; Reijers, Sophie J M; Asher, Nethanel; Broman, Kristy K; Duncan, Zoey; Anderson, Matilda; Gyorki, David E; Snow, Hayden; Held, Jenny; Farma, Jeffrey M; Vetto, John T; Hui, Jane Y C; Kolbow, Madison; Saw, Robyn P M; Lo, Serigne N; Long, Georgina V; Thompson, John F; Kim, Youngchul; Karapetyan, Lilit; Ny, Lars; van Akkooi, Alexander C J; Olofsson Bagge, Roger; Zager, Jonathan S

Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalation

皮肤鳞状细胞癌患者选择性停用PD-1抑制剂后的临床结果:探索治疗降阶方案

Averbuch, Itamar; Edri, Nofar; Asher, Nethanel; Markel, Gal; Hendler, Daniel; Ditzian Kugler, Hadas; Yosefof, Eyal; Kurman, Noga

Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients

免疫功能低下患者非黑色素瘤皮肤癌患者接受程序性死亡受体1抑制剂治疗的疗效及实体器官移植患者亚组分析

Yosefof, Eyal; Edri, Nofar; Ben-Nachum, Idan; Yaniv, Dan; Mizrachi, Aviram; Asher, Nethanel; Ben-Dor, Naomi; Ben-Artzi, Avital; Averbuch, Itamar; Kurman, Noga

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma

黑色素瘤患者使用免疫检查点抑制剂后发生神经系统免疫相关不良事件的发生率和预后

Pepys, Jack; Stoff, Ronen; Ramon-Gonen, Roni; Ben-Betzalel, Guy; Grynberg, Shirly; Frommer, Ronnie Shapira; Schachter, Jacob; Asher, Nethanel; Taliansky, Alisa; Nikitin, Vera; Dori, Amir; Shelly, Shahar

Modular Drug-Loaded Nanocapsules with Metal Dome Layers as a Platform for Obtaining Synergistic Therapeutic Biological Activities

具有金属圆顶层的模块化载药纳米胶囊作为获得协同治疗生物活性的平台

Arnon Fluksman, Aritz Lafuente, Ron Braunstein, Eliana Steinberg, Nethanel Friedman, Zhanna Yekhin, Alejandro G Roca, Josep Nogues, Ronen Hazan, Borja Sepulveda, Ofra Benny

A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine

完全 3D 打印的多功能肿瘤芯片可进行多药筛选并与个性化医疗的临床结果相关联

Eliana Steinberg, Roy Friedman, Yoel Goldstein, Nethanel Friedman, Ofer Beharier, Jonathan Abraham Demma, Gideon Zamir, Ayala Hubert, Ofra Benny

Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy

亡羊补牢,为时未晚:类固醇治疗对接受免疫疗法治疗的黑色素瘤患者预后的影响

Bar-Hai, Neta; Ben-Betzalel, Guy; Stoff, Ronen; Grynberg, Shirly; Schachter, Jacob; Shapira-Frommer, Ronnie; Asher, Nethanel

The Implications of a Dermatopathologist's Report on Melanoma Diagnosis and Treatment

皮肤病理学家关于黑色素瘤诊断和治疗的报告的意义

Nethanel, Asher; Kyprianou, Christofis; Barzilai, Aviv; Shapira-Frommer, Ronnie; Shoham, Yaron; Kornhaber, Rachel; Cleary, Michelle; Avinoam-Dar, Galit; Grynberg, Shirly; Haik, Josef; Debby, Assaf; Harats, Moti